Navigation Links
Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765
Date:12/7/2009

NEW ORLEANS and SUNNYVALE, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced interim data from a Phase I study of their novel orally administered Bruton's tyrosine kinase (Btk) inhibitor PCI-32765 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) or chronic lymphocytic leukemia (CLL). These data are being presented at the American Society of Hematology (ASH) 51st Annual Meeting taking place this week in New Orleans, LA.

The multi-center dose escalation Phase I study is being conducted in collaboration with investigators at leading lymphoma centers including Stanford University, MD Anderson Cancer Center, the University of Chicago, the University of Vermont, and US Oncology group. The trial was designed to explore up to 6 dose levels with a minimum of 4 evaluable patients per cohort. Each cycle of treatment consists of 28 consecutive days of dosing followed by 7 days of rest. Safety is evaluated at the end of the first cycle and efficacy at the end of the second. At least one full cycle of treatment has been completed for each patient in the first 3 cohorts. Data from the second cohort demonstrated that PCI-32765 fully occupied the active site of the target enzyme Btk in peripheral blood cells with minimal variability, fully inhibited surrogate biomarkers for up to 24 hours, and was well tolerated by patients.

In the first 2 dose cohorts, 16 heavily pretreated and progressing lymphoma patients with a variety of B-cell malignancies were evaluated. In the first dose cohort, 7 patients were treated with PCI-32765 resulting in 2 partial responses (e.g. a 50% decrease in sum of the product of the diameters of up to 6 largest dominant masses; no increase in size of other nodes per the Revised Response Criteria for Malignant Lymphoma Bruce D. Cheson J Clin
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting
2. Patriot Scientific Corporation Announces New Director
3. Lilly Announces the First 300-unit Vial of Insulin
4. Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S.
5. The Countrys Largest Cooking Magazine Announces The Comfort Food Diet Cookbook
6. BridgeGate International Announces New Integration and Interoperability Training Program
7. NBTY To Webcast Presentation; Wedbush Securities California Dreamin Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009
8. Distributor Announces New Applications for Wind Turbines
9. FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover
10. NeoGenomics Announces Executive Appointments
11. Hill-Rom Announces First Quarter 2010 Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, a locally ... effort to provide for the family of Grace, a young local girl battling ... often leads to diastolic dysfunction – the inability to adequately move blood through ...
(Date:9/4/2015)... Monroe, NC (PRWEB) , ... September 04, 2015 ... ... Girl’s Night out to benefit Core Compassion Project. Core Compassion Project is ... a specialized program to reduce the side effects of cancer treatments and recover ...
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
(Date:9/4/2015)... ... ... Many consumers are looking for a quick and convenient way to produce a hot remedy ... Cups provide a quick and simple way to brew a hot cup of cold remedy ... a result, they enhance comfort and health. The invention features a novel design that is ...
(Date:9/4/2015)... ... 04, 2015 , ... The conference program for the upcoming ... 9-10, 2015 at the Diplomat Resort & Spa has been announced and is ... at the top of their field and will be presenting sessions such as ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... a maximum residue limit (MRL) of one part per billion in ... that the limit should be enforced through legislation in order to ... chairman of the Indian Council of Medical Research N K Ganguly. ... 2004, in the wake of a controversy over pesticide residues in ...
... court has handed down a one-year suspended jail sentence to ... to a terminally ill cancer patient.// ,Doctor Laurence ... for poisoning Paulette Druais, a 65-year-old woman in 2003. ... in Saint-Astier in the southwestern Dordogne region. ,At ...
... to homicide, HIV disease, accidental injuries and heart ailments, especially ... reduction in the life expectancy gap between blacks and whites ... study is published in the March 21 issue of JAMA. ... increasing in the United States since at least the late ...
... The mineral zinc, which is present in every part of ... says a study that could help// in the development of ... contribute to the formation of plaques in the brains of ... healthy working of many of the body's systems. ...
... cancer, many men are told that their disease is untreatable ... patients are told to watch and wait -- that is, ... that either surgical removal of the prostate (prostatectomy) or radiation ... when compared with those receiving the conservative approach. ...
... conducted by Glenn Good and team from University of Missouri, ... of neurological injuries//. While it has been assumed all along ... study offers a new dimension to this issue. ... of their health. But the same quality is said to ...
Cached Medicine News:Health News:French 'euthanasia Doctor' Avoids Jail 2Health News:Black-white Life Expectancy Gap Reduces, Yet Remains Significant 2Health News:Surgery, Radiation Treatment Double Life Expectancy for Prostate Cancer Patients 2
(Date:9/3/2015)... population of more than 1 billion, China is the ... potential market for goods and services. In the past ... in the average rate of growth in real GDP, ... in vitro diagnostics (IVD) market, China trails only the ... countries, and Japan. China represents one of the largest ...
(Date:9/3/2015)... 2015 About self-monitoring blood glucose device ... electronic device. It consists of a glucose sensor ... levels through radiowaves from the sensor to a ... of self-monitoring blood glucose devices can improve self-management ... proper diabetes treatment. Technavio,s analysts forecast ...
(Date:9/3/2015)... 2015 About cardiovascular implants ... narrowing or blockage of blood vessels. Cardiac disease ... high cholesterol, and high blood pressure. Coronary artery ... heart failure are some of the major cardiac ... especially coronary arteries, is one of the most ...
Breaking Medicine Technology:IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Global Self-monitoring Blood Glucose Devices Market 2015-2019 2Global Cardiovascular Implants Market 2015-2019 2
... SAN DIEGO, Sept. 1, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... and Chief Executive Officer of Neurocrine Biosciences, will be presenting ... The live presentation takes place on Thursday, ... a.m. Pacific Time.  The presentation will be webcast and may ...
... Sept. 1, 2011 The CVS Caremark Charitable Trust, ... a donation of $75,000 to the American Red Cross ... east coast of the United States impacted by Hurricane ... free water, ice and other supplies to local residents ...
Cached Medicine Technology:CVS Caremark Charitable Trust and CVS/pharmacy Provide Over $100,000 in Disaster Relief To Communities Impacted by Hurricane Irene 2
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
... ergonomic solution and best value in high ... action and ultra lightweight design reduce hand ... with long, lever tip ejector , Color ... universal tips or for greater performance use ...
... Finnpipette BioControl multichannel has ... as the single channel ... fits all seven multichannel ... tip cone modules. Both ...
Medicine Products: